ACE DD genotype: An independent predisposition factor to venous thromboembolism

C. Fatini, F. Gensini, E. Sticchi, B. Battaglini, D. Prisco, S. Fedi, T. Brunelli, R. Marcucci, A. A. Conti, G. F. Gensini, Rossana Abbate

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background: The renin angiotensin system affects haemostasis through different mechanisms; data on the possible role of angiotensin-converting enzyme I/D polymorphism in the pathogenesis of deep venous thrombosis are conflicting, and no information is available regarding the A1166C polymorphism of the angiotensin type 1 receptor gene. In order to investigate this issue, angiotensin-converting enzyme and AT1R polymorphisms were genotyped in 336 consecutive venous thromboembolism patients and 378 controls. Materials and methods: Haemostasis-related risk factors have been evaluated by routine tests. Factor V Leiden, Factor II (G20210A), angiotensin-converting enzyme (I/D), and angiotensin type 1 receptor (A1166C) polymorphisms have been identified by molecular analysis. Results: We documented a significant association between angiotensin-converting enzyme DD genotype and venous thromboembolism (OR = 2.19 95%CI 1.51-3.17 adjusted for acquired and haemostasis-related risk factors, P <0.0001); in patients with haemostasis-related risk factors, angiotensin-converting enzyme DD genotype modified the risk of venous thromboembolism in hyperhomocysteinaemic and Factor V Leiden patients and was associated with the risk of recurrent venous thromboembolism (OR = 1.83 95%CI 1.06-3.17 P = 0.03). In patients without haemostasis-related risk factors the angiotensin-converting enzyme DD genotype was still an independent predictor of venous thromboembolism (OR = 3.29 95%CI 2.17-4.98 adjusted for acquired risk factors, P <0.0001). No significant association between the angiotensin type 1 receptor CC genotype and venous thromboembolism was found. Conclusions: This study shows that angiotensin-converting enzyme DD genotype represents a susceptibility marker of thrombosis in subjects apparently without predisposing factors and traditional thrombophilic alterations, and increases the risk of venous thromboembolism in subjects in whom a thrombogenic condition occurs. Moreover, angiotensin-converting enzyme DD genotype may be considered a new predisposing factor to venous thromboembolism recurrence.

Original languageEnglish
Pages (from-to)642-647
Number of pages6
JournalEuropean Journal of Clinical Investigation
Volume33
Issue number8
DOIs
Publication statusPublished - Aug 1 2003

Fingerprint

Venous Thromboembolism
Peptidyl-Dipeptidase A
Genotype
Hemostasis
Polymorphism
Angiotensin Type 1 Receptor
Causality
Angiotensins
Renin-Angiotensin System
Renin
Venous Thrombosis
Thrombosis
Genes
Recurrence

Keywords

  • ACE gene
  • AT1R gene
  • Polymorphism
  • Thrombophilia
  • Venous thromboembolism

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fatini, C., Gensini, F., Sticchi, E., Battaglini, B., Prisco, D., Fedi, S., ... Abbate, R. (2003). ACE DD genotype: An independent predisposition factor to venous thromboembolism. European Journal of Clinical Investigation, 33(8), 642-647. https://doi.org/10.1046/j.1365-2362.2003.01185.x

ACE DD genotype : An independent predisposition factor to venous thromboembolism. / Fatini, C.; Gensini, F.; Sticchi, E.; Battaglini, B.; Prisco, D.; Fedi, S.; Brunelli, T.; Marcucci, R.; Conti, A. A.; Gensini, G. F.; Abbate, Rossana.

In: European Journal of Clinical Investigation, Vol. 33, No. 8, 01.08.2003, p. 642-647.

Research output: Contribution to journalArticle

Fatini, C, Gensini, F, Sticchi, E, Battaglini, B, Prisco, D, Fedi, S, Brunelli, T, Marcucci, R, Conti, AA, Gensini, GF & Abbate, R 2003, 'ACE DD genotype: An independent predisposition factor to venous thromboembolism', European Journal of Clinical Investigation, vol. 33, no. 8, pp. 642-647. https://doi.org/10.1046/j.1365-2362.2003.01185.x
Fatini, C. ; Gensini, F. ; Sticchi, E. ; Battaglini, B. ; Prisco, D. ; Fedi, S. ; Brunelli, T. ; Marcucci, R. ; Conti, A. A. ; Gensini, G. F. ; Abbate, Rossana. / ACE DD genotype : An independent predisposition factor to venous thromboembolism. In: European Journal of Clinical Investigation. 2003 ; Vol. 33, No. 8. pp. 642-647.
@article{7e9573cf8e1a44ac850399216914ae23,
title = "ACE DD genotype: An independent predisposition factor to venous thromboembolism",
abstract = "Background: The renin angiotensin system affects haemostasis through different mechanisms; data on the possible role of angiotensin-converting enzyme I/D polymorphism in the pathogenesis of deep venous thrombosis are conflicting, and no information is available regarding the A1166C polymorphism of the angiotensin type 1 receptor gene. In order to investigate this issue, angiotensin-converting enzyme and AT1R polymorphisms were genotyped in 336 consecutive venous thromboembolism patients and 378 controls. Materials and methods: Haemostasis-related risk factors have been evaluated by routine tests. Factor V Leiden, Factor II (G20210A), angiotensin-converting enzyme (I/D), and angiotensin type 1 receptor (A1166C) polymorphisms have been identified by molecular analysis. Results: We documented a significant association between angiotensin-converting enzyme DD genotype and venous thromboembolism (OR = 2.19 95{\%}CI 1.51-3.17 adjusted for acquired and haemostasis-related risk factors, P <0.0001); in patients with haemostasis-related risk factors, angiotensin-converting enzyme DD genotype modified the risk of venous thromboembolism in hyperhomocysteinaemic and Factor V Leiden patients and was associated with the risk of recurrent venous thromboembolism (OR = 1.83 95{\%}CI 1.06-3.17 P = 0.03). In patients without haemostasis-related risk factors the angiotensin-converting enzyme DD genotype was still an independent predictor of venous thromboembolism (OR = 3.29 95{\%}CI 2.17-4.98 adjusted for acquired risk factors, P <0.0001). No significant association between the angiotensin type 1 receptor CC genotype and venous thromboembolism was found. Conclusions: This study shows that angiotensin-converting enzyme DD genotype represents a susceptibility marker of thrombosis in subjects apparently without predisposing factors and traditional thrombophilic alterations, and increases the risk of venous thromboembolism in subjects in whom a thrombogenic condition occurs. Moreover, angiotensin-converting enzyme DD genotype may be considered a new predisposing factor to venous thromboembolism recurrence.",
keywords = "ACE gene, AT1R gene, Polymorphism, Thrombophilia, Venous thromboembolism",
author = "C. Fatini and F. Gensini and E. Sticchi and B. Battaglini and D. Prisco and S. Fedi and T. Brunelli and R. Marcucci and Conti, {A. A.} and Gensini, {G. F.} and Rossana Abbate",
year = "2003",
month = "8",
day = "1",
doi = "10.1046/j.1365-2362.2003.01185.x",
language = "English",
volume = "33",
pages = "642--647",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Blackwell Publishing Ltd",
number = "8",

}

TY - JOUR

T1 - ACE DD genotype

T2 - An independent predisposition factor to venous thromboembolism

AU - Fatini, C.

AU - Gensini, F.

AU - Sticchi, E.

AU - Battaglini, B.

AU - Prisco, D.

AU - Fedi, S.

AU - Brunelli, T.

AU - Marcucci, R.

AU - Conti, A. A.

AU - Gensini, G. F.

AU - Abbate, Rossana

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Background: The renin angiotensin system affects haemostasis through different mechanisms; data on the possible role of angiotensin-converting enzyme I/D polymorphism in the pathogenesis of deep venous thrombosis are conflicting, and no information is available regarding the A1166C polymorphism of the angiotensin type 1 receptor gene. In order to investigate this issue, angiotensin-converting enzyme and AT1R polymorphisms were genotyped in 336 consecutive venous thromboembolism patients and 378 controls. Materials and methods: Haemostasis-related risk factors have been evaluated by routine tests. Factor V Leiden, Factor II (G20210A), angiotensin-converting enzyme (I/D), and angiotensin type 1 receptor (A1166C) polymorphisms have been identified by molecular analysis. Results: We documented a significant association between angiotensin-converting enzyme DD genotype and venous thromboembolism (OR = 2.19 95%CI 1.51-3.17 adjusted for acquired and haemostasis-related risk factors, P <0.0001); in patients with haemostasis-related risk factors, angiotensin-converting enzyme DD genotype modified the risk of venous thromboembolism in hyperhomocysteinaemic and Factor V Leiden patients and was associated with the risk of recurrent venous thromboembolism (OR = 1.83 95%CI 1.06-3.17 P = 0.03). In patients without haemostasis-related risk factors the angiotensin-converting enzyme DD genotype was still an independent predictor of venous thromboembolism (OR = 3.29 95%CI 2.17-4.98 adjusted for acquired risk factors, P <0.0001). No significant association between the angiotensin type 1 receptor CC genotype and venous thromboembolism was found. Conclusions: This study shows that angiotensin-converting enzyme DD genotype represents a susceptibility marker of thrombosis in subjects apparently without predisposing factors and traditional thrombophilic alterations, and increases the risk of venous thromboembolism in subjects in whom a thrombogenic condition occurs. Moreover, angiotensin-converting enzyme DD genotype may be considered a new predisposing factor to venous thromboembolism recurrence.

AB - Background: The renin angiotensin system affects haemostasis through different mechanisms; data on the possible role of angiotensin-converting enzyme I/D polymorphism in the pathogenesis of deep venous thrombosis are conflicting, and no information is available regarding the A1166C polymorphism of the angiotensin type 1 receptor gene. In order to investigate this issue, angiotensin-converting enzyme and AT1R polymorphisms were genotyped in 336 consecutive venous thromboembolism patients and 378 controls. Materials and methods: Haemostasis-related risk factors have been evaluated by routine tests. Factor V Leiden, Factor II (G20210A), angiotensin-converting enzyme (I/D), and angiotensin type 1 receptor (A1166C) polymorphisms have been identified by molecular analysis. Results: We documented a significant association between angiotensin-converting enzyme DD genotype and venous thromboembolism (OR = 2.19 95%CI 1.51-3.17 adjusted for acquired and haemostasis-related risk factors, P <0.0001); in patients with haemostasis-related risk factors, angiotensin-converting enzyme DD genotype modified the risk of venous thromboembolism in hyperhomocysteinaemic and Factor V Leiden patients and was associated with the risk of recurrent venous thromboembolism (OR = 1.83 95%CI 1.06-3.17 P = 0.03). In patients without haemostasis-related risk factors the angiotensin-converting enzyme DD genotype was still an independent predictor of venous thromboembolism (OR = 3.29 95%CI 2.17-4.98 adjusted for acquired risk factors, P <0.0001). No significant association between the angiotensin type 1 receptor CC genotype and venous thromboembolism was found. Conclusions: This study shows that angiotensin-converting enzyme DD genotype represents a susceptibility marker of thrombosis in subjects apparently without predisposing factors and traditional thrombophilic alterations, and increases the risk of venous thromboembolism in subjects in whom a thrombogenic condition occurs. Moreover, angiotensin-converting enzyme DD genotype may be considered a new predisposing factor to venous thromboembolism recurrence.

KW - ACE gene

KW - AT1R gene

KW - Polymorphism

KW - Thrombophilia

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=0042666940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042666940&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2362.2003.01185.x

DO - 10.1046/j.1365-2362.2003.01185.x

M3 - Article

C2 - 12864773

AN - SCOPUS:0042666940

VL - 33

SP - 642

EP - 647

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 8

ER -